Pooled analyses of immune-related adverse events (irAEs) and efficacy from the phase 3 trials IMpower130, IMpower132, and IMpower150. Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Socinski, Mark A.; Jotte, Robert M.; Cappuzzo, Federico; Nishio, Makoto; Mok, Tony S. K.; Reck, Martin; Finley, Gene Grant; Yu, Wei; Patel, Hina; Paranthaman, Nindhana; Bara, Ilze; West, Howard

Publication Date

  • May 20, 2021

webpage

published in

category

volume

  • 39

issue

  • 15